148
Views
2
CrossRef citations to date
0
Altmetric
Articles

Omega-3 fatty acids differentially influences embryotoxicity in subtypes of preeclampsia

, , , &
Pages 205-212 | Received 15 Jan 2019, Accepted 26 Mar 2019, Published online: 09 Apr 2019

References

  • Kelly BA, Kyriakou T, Leeson P. Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies. Clin Sci. 2012;123(2):53–72. doi:10.1042/CS20110627.
  • Myatt L, Redman CW, Staff AC, Hansson S, Wilson ML, Laivuori H, Poston L, Roberts JM. Strategy for standardization of preeclampsia research study design novelty and significance. Hypertension. 2014;63(6):1293–301. doi:10.1161/HYPERTENSIONAHA.113.02664.
  • Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstetri & gynecol survey. 2011; 66(8):497–506. Atluri S, Manoli NS. Comparative study of maternal and perinatal outcome in early onset and late onset preeclampsia. J Evidence Based Med Healthcare. 2017;4(9):499–504.
  • Mifsud W, Sebire NJ. Placental pathology in early-onset and late-onset fetal growth restriction. Fetal Diagn Ther. 2014;36(2):117–28. doi:10.1159/000359969.
  • Parra-Cordero M, Rodrigo R, Barja P, Bosco C, Rencoret G, et al. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery doppler and markers of vasculogenesis during first trimester of pregnancy. Ultrasound Obstet Gynecol. 2013; 41(5):538–44.
  • Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two differentmaternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52(5):873–80. doi:10.1161/HYPERTENSIONAHA.108.117358.
  • Muresan D, Rotar IC, Stamatian F. The usefulness of fetal Doppler evaluation in early versus late onset intrauterine growth restriction. Review of the literature. Med Ultrason. 2016;18(1):103–09. doi:10.11152/mu.2013.2066.181.dop.
  • Rani A, Meher A, Wadhwani N, Joshi S. Altered development and function of the placental regions in preeclampsia and its association with long‐chain polyunsaturated fatty acids. WIREs Dev Biol. 2016;5:582–97. doi:10.1002/wdev.238.
  • Hubinont C, Savoye T. Maternal and fetal benefits of DHA supplementation during pregnancy. Journal of Pregnancy Reproduction. 2017;1. DOI:10.15761/JPR.1000103.
  • Horvath A, Koletzko B, Szajewska H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr. 2007;98(2):253–59. doi:10.1017/S0007114507709078.
  • Bernardi JR, Escobar RD, Ferreira CF, Silveira PP. Fetal and neonatal levels of omega-3: effects on neurodevelopment, nutrition, and growth. Sci World J. 2012;2012:202473. doi:10.1100/2012/202473.
  • Carvajal JA. Docosahexaenoic acid supplementation early in pregnancy may prevent deep placentation disorders. Biomed Res Int. 2014; 2014:526895.
  • Oken E. Consumption of fish and long-chain n-3 polyunsaturated fatty acids during pregnancy: has the tide turned? Paediatr Perinat Epidemiol. 2015;29(5):388–90. doi:10.1111/ppe.12214.
  • Mehendale S, Kilari A, Dangat K, Taralekar V, Mahadik S, Joshi S. Fatty acids, antioxidants, and oxidative stress in pre‐eclampsia. Int J Gynecol & Obstet. 2008;100(3):234–38. doi:10.1016/j.ijgo.2007.08.011.
  • Ramakrishnan U, Stein AD, Parra-Cabrera S, Wang M, Imhoff-Kunsch B, Juirez-Marquez S, et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull. 2010;31(2 Suppl):S108–16. doi:10.1177/15648265100312S203.
  • Sahay AS, Sundrani DP, Wagh GN, Mehendale SS, Joshi SR. Regional differences in the placental levels of oxidative stress markers in pre-eclampsia. Int J Gynecol & Obstet. 2015;129(3):213–18. doi:10.1016/j.ijgo.2015.03.001.
  • Kemse NG, Kale AA, Joshi SR. Supplementation of maternal omega-3 fatty acids to pregnancy induced hypertension Wistar rats improves IL10 and VEGF levels. Plefa. 2016;104:25–32. doi:10.1016/j.plefa.2015.11.003.
  • Ayala A, Munoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438. doi:10.1155/2014/360438.
  • Sahay AS, Sundrani DP, Wagh GN, Mehendale SS, Joshi SR. Regional differences in the placental levels of oxidative stress markers in pre-eclampsia. International Journal of Gynecology & Obstetrics. 2015;129(3):213-8.
  • Jones ML, Mark PJ, Waddell BJ. Maternal dietary omega-3 fatty acids and placental function. Reproduction. 2014;147(5):R143–52. doi:10.1530/REP-13-0376.
  • Conde-Agudelo A, Romero R, Kusanovic JP, Hassan SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Amn J Obstetr Gynecol. 2011;204(6):503.e1–12. doi:10.1016/j.ajog.2011.02.020.
  • Vijayalakshmi B, Ambareesha K, Kayalvizhi E, Chandrasekhar M. Effect of antioxidants in preeclampsia women at increased risk, International. J Med Res Health Sci. 2013;2(2):177–81. doi:10.5958/j.2319-5886.2.2.025.
  • Basaran A, Basaran M, Topatan B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstet Gynecol Surv. 2010;65(10):653–67. doi:10.1097/OGX.0b013e3182095366.
  • Rumbold A, Ota E, Hori H, Miyazaki C, Crowther CA. Vitamin E supplementation in pregnancy. Cochrane Database Syst Rev. 2015;9:CD004069.
  • Fonseca BM, Correia-da-Silva G, Teixeira NA. The rat as an animal model for fetoplacental development: a reappraisal of the post-implantation period. Reprod Biol. 2012;12(2):97–118.
  • Valentin J. Doses to the Embryo and Fetus from Intakes of Radionuclides by the Mother. ICRP Publication 89. Annals of the ICRP. 2001;31(1–3):29–47.
  • Silva JF, Serakides R. Intrauterine trophoblast migration: A comparative view of humans and rodents. Cell Adh Migr. 2016;10(1–2):88–110. doi:10.1080/19336918.2015.1120397.
  • Vercruysse L, Caluwaerts S, Luyten C, Pijnenborg R. Interstitial trophoblast invasion in the decidua and mesometrial triangle during the last third of pregnancy in the rat. Placenta. 2006;27(1):22–33. doi:10.1016/j.placenta.2004.11.004.
  • Patten AR, Fontaine CJ, Christie BR. A comparison of the different animal models of fetal alcohol spectrum disorders and their use in studying complex behaviors. Front Pediatr. 2014;2:93. doi:10.3389/fped.2014.00093.
  • Dong X, Shi D. Simvastatin alleviates pathology in a rat model of preeclampsia involving ERK/MAPK pathway. Reprod Sci. 2017;24(7):1053–61. doi:10.1177/1933719116678693.
  • Brown C, McFarlane-Anderson N, Alexander-Lindo R, Bishop K, Dasgupta T et al. The effects of S-nitrosoglutathione and S-nitroso-N-acetyl-D, Lpenicillamine in a rat model of pre-eclampsia. J Nat Sci Biol Med. 2013;4(2):330–35. doi:10.4103/0976-9668.116998.
  • Mayr AJ, Lederer W, Wolf HJ, Dunser M, Pfaller K, Mortle MG. Morphologic changes of the uteroplacental unit in preeclampsia-like syndrome in rats. Hypertens Pregnancy. 2005;24(1):29–37. doi:10.1081/PRG-45770.
  • Lien EL, Boyle FG, Wrenn JM, Perry RW, Thompson CA, Borzelleca JF. Comparison of AIN-76A and AIN-93G diets: a 13-week study in rats. Food Chem Toxicol. 2001;39(4):385–92.
  • Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med. 2008;233(6):674–88.
  • McCarthy FP, Kenny LC, Walsh SK. Animal models of preeclampsia; uses and limitations. Placenta. 2011;32(6):413–19. doi:10.1016/j.placenta.2011.03.010.
  • Nandi A, Wadhwani N, Joshi SR. Vitamin D deficiency influences fatty acid metabolism. Prostaglandins, Leukotrienes Essent Fatty Acids. 2019;140:57–63. DOI:10.1016/j.plefa.2018.11.014.
  • AbuMweis S, Jew S, Tayyem R, Agraib L. Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials. J Hum Nutr Diet. 2018;31(1):67–84. doi:10.1111/jhn.12493.
  • Podjarny E, Losonczy G, Baylis C. Animal models of preeclampsia. Semin Nephrol. 2004;24(6):596–606.
  • Podjarny E, Benchetrit S, Katz B, Green J, Bernheim J. Effect of methyldopa on renal function in rats with L-NAME-induced hypertension in pregnancy. Nephron. 2001;88(4):354–59. doi:10.1159/000046020.
  • Ferrazzani S, Luciano R, Garofalo S, D‘Andrea V, De Carolis S, De Carolis MP, Paolucci V, Romagnoli C, Caruso A. Neonatal outcome in hypertensive disorders of pregnancy. Early Hum Dev. 2011; 87(6):445–49. doi:10.1016/j.earlhumdev.2011.03.005.
  • Van Esch JJ, Van Heijst AF, De Haan AF. Van der Heijden OW. Early-onset preeclampsia is associated with perinatal mortality and severe neonatal morbidity. J Maternal-Fetal & Neonatal Med. 2017; 30(23):2789–94. doi:10.1080/14767058.2016.1263295.
  • Mitsui T, Masuyama H, Eto E, Nobumoto E, Hayata K, Different Fetal HY. Different Fetal and Neonatal Growth between Early-and Late-Onset Preeclampsia. Open J Obstetr and Gynecol. 2015; 5(09):516. doi:10.4236/ojog.2015.59074.
  • Hoshi T, Wissuwa B, Tian Y, Tajima N, Xu R, Bauer M, Heinemann SH, Hou S. Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca2+-dependent K+ channels. Pnas. 2013;110(12):4816–21. doi:10.1073/pnas.1221997110.
  • Zana-Taieb E, Butruille L, Franco-Montoya M-L, Lopez E, Vernier F, Grandvuillemin I, Evain-Brion D, Deruelle P, Baud O, Delacourt C, et al. Effect of two models of intrauterine growth restriction on alveolarization in rat lungs: morphometric and gene expression analysis. PLoS One. 2013;8(11):e78326. doi:10.1371/journal.pone.0078326.
  • Liu JC, Conklin SM, Manuck SB, Yao JK, Muldoon MF. Long-chain omega-3 fatty acids and blood pressure. Am j Hypertens. 2011;24(10):1121–26. doi:10.1038/ajh.2011.120.
  • Mistry HD, Williams PJ. The importance of antioxidant micronutrients in pregnancy. Oxid Med Cell Longev. 2011;2011:841749. doi:10.1155/2011/841749.
  • Tiboni GM, Giampietro F, Di Giulio C. The nitric oxide synthesis inhibitor nn ω-nitro-L-arginine methyl ester (L-NAME) causes limb defects in mouse fetuses: protective effect of acute hyperoxia. Pediatr Res. 2003;54(1):69–76. doi:10.1203/01.PDR.0000069840.78984.76.
  • Ladipo OA. Nutrition in pregnancy: mineral and vitamin supplements. Am J Clin Nutr. 2000;72(1 Suppl):280S–290S. doi:10.1093/ajcn/72.1.280S.
  • Yakoob MY, Khan YP, Bhutta ZA. Maternal mineral and vitamin supplementation in pregnancy. Expert Rev Obstet Gynecol. 2010;5(2):241–56. doi:10.1586/eog.10.8.
  • Kiondo P, Wamuyu-Maina G, Wandabwa J, Bimenya GS, Tumwesigye NM, Okong P. The effects of vitamin C supplementation on pre-eclampsia in Mulago Hospital, Kampala, Uganda: a randomized placebo controlled clinical trial. BMC Pregnancy Childbirth. 2014;1:283. DOI:10.1186/1471-2393-14-283.
  • McCance DR, Holmes VA, Maresh MJ, Patterson CC, Walker JD, Pearson DW, Young IS. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. The Lancet. 2010; 376(9737):259–66. doi:10.1016/S0140-6736(10)60630-7.
  • Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol. 2005; 192(2):520–21. doi:10.1016/j.ajog.2004.09.005.
  • Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. for the Vitamins in Pre-eclampsia (VIP) Trial Consortium Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet. 2006;367:1145–54. doi:10.1016/S0140-6736(06)68433-X.
  • Xu H, Perez-Cuevas R, Xiong X. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol. 2010;202:239.e1–239.e10. doi:10.1016/j.ajog.2010.01.050.
  • Spinnato JA, Freire S, Pinto E. Antioxidant therapy to prevent pre-eclampsia: a randomised controlled trial. Obstet Gynecol. 2007;110:1311–18. doi:10.1097/01.AOG.0000289576.43441.1f.
  • Fu ZM, Ma ZZ, Liu GJ, Wang LL, Guo Y. Vitamins supplementation affects the onset of preeclampsia. J Formos Med Assoc. 2018;117(1):6–13. doi:10.1016/j.jfma.2017.08.005.
  • Conde-Agudelo A, Romero R, Kusanovic JP, Hassan SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011; 204(6):503–e1. doi:10.1016/j.ajog.2011.02.020.
  • Basaran A, Basaran M, Topatan B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstet Gynecol Surv. 2010; 65(10):653–67. doi:10.1097/OGX.0b013e3182095366.
  • Rahimi R, Nikfar S, Rezaie A, Abdollahi M. A meta-analysis on the efficacy and safety of combined vitamin C and E supplementation in preeclamptic women. Hypertension in Pregnancy. 2009; 28(4):417–34. doi:10.3109/10641950802629667.
  • Shennan AH, Duckworth S. Use of vitamin C and E to prevent preeclampsia. Obstetric Medicine. 2010; 3(3):121–22. doi:10.1258/om.2010.100037.
  • Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: beyond eNOS. J Pharmacol Sci. 2015; 129(2):83–94. doi:10.1016/j.jphs.2015.09.002.
  • Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829–37, 837a-837d. doi:10.1093/eurheartj/ehr304.
  • Fleming I. Molecular mechanisms underlying the activation of eNOS. Pflügers Archiv-Eur J Physiol. 2010;459(6):793–806. doi:10.1007/s00424-009-0767-7.
  • Sandoo A, Van Zanten JJ, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J. 2010;4:302–12. doi:10.2174/1874192401004010302.
  • Dickson EJ, Jensen JB, Hille B. Regulation of calcium and phosphoinositides at endoplasmic reticulum–membrane junctions. Biochem Soc Trans. 2016;44(2):467–73. doi:10.1042/BST20150262.
  • Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol. 2007;42(2):271–79. doi:10.1016/j.yjmcc.2006.05.023.
  • Stuehr DJ. Enzymes of the L-arginine to nitric oxide pathway. J Nutr. 2004;134(10 Suppl):2748S–2751S. doi:10.1093/jn/134.10.2748S.
  • Bae SW, Kim HS, Cha YN, Park YS, Jo SA, Jo I. Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signalling pathway. Biochem Biophys Res Commun. 2003;306(4):981–87.
  • Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul, IntegrComp Physiol. 2003;284(1):R1–12. doi:10.1152/ajpregu.00323.2002.
  • Wang R, Szabo C, Ichinose F, Ahmed A, Whiteman M, Papapetropoulos A. The role of H2S bioavailability in endothelial dysfunction. Trends Pharmacol Sci. 2015;36(9):568–78. doi:10.1016/j.tips.2015.05.007.
  • Hefler LA, Reyes CA, O’Brien WE, Gregg AR. Perinatal development of endothelial nitric oxide synthase-deficient mice. Biol Reprod. 2001;64(2):666–73.
  • Kemse NG, Kale AA, Joshi SR. A combined supplementation of omega-3 fatty acids and micronutrients (folic acid, vitamin B12) reduces oxidative stress markers in a rat model of pregnancy induced hypertension. PLoS One. 2014;9(11):e111902. doi:10.1371/journal.pone.0111902.
  • Sargi SC, Dalalio MM, Moraes AG, Visentainer JE, Morais DR, Visentainer JV. Role of omega-3 polyunsaturated fatty acids in the production of prostaglandin E2 and nitric oxide during experimental murine paracoccidioidomycosis. Biomed Res Int. 2013;2013:947687. doi:10.1155/2013/947687.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.